Breaking News

Olon Group Acquires GTP Bioways

Expands capabilities for the development and production of ADCs.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Olon Group has strengthened its CDMO capabilities with the acquisition of GTP Bioways Group, a French company operating as Biotech CDMO and specializing in R&D services, process development and production of mAbs, enzymes, proteins, nanodrugs, ADCs and fill-finish. GTP Bioways operates a total of four sites in France (Toulouse, Labege, Veyre-Monton, and Saint-Julien-en-Genevois) focused on development, clinical trial and cGMP manufacturing. The headquarters are based in Toulouse. “Th...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters